SPC
IART icon

Sigma Planning Corp’s Integra LifeSciences IART Stock Holding History

Sigma Planning Corp’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-40,636
Closed -$2.62M – 974
2018
Q2 		$2.62M Sell
40,636
-21
-0.1% -$1.3K 0.18% 132
2018
Q1 		$2.25M Buy
+40,657
New +$2.13M 0.16% 149

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sigma Planning Corp's IART Position: Q3 2018 in Review

Sigma Planning Corp sold out of Integra LifeSciences (IART) in Q3 2018, closing a stake of 40,636 shares — an estimated $2.62M sold.

Sigma Planning Corp first reported a position in IART in Q1 2018 and held it in 2 quarters. The position peaked at $2.62M in Q2 2018. 249 funds tracked by Wall St. Rank hold IART as of Q3 2018.

  • Sigma Planning Corp reported no remaining Integra LifeSciences position as of Q3 2018 after selling out during the quarter.
  • Sigma Planning Corp sold 40,636 Integra LifeSciences shares in Q3 2018, an estimated $2.62M.
  • Sigma Planning Corp first reported a position in Integra LifeSciences in Q1 2018 and held it in 2 quarters.
  • Sigma Planning Corp's Integra LifeSciences position peaked at $2.62M in Q2 2018.
  • 249 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2018.

Based on Sigma Planning Corp's 13F filing for Q3 2018, filed 7 Nov 2018.